RAPALOGIX HEALTH, INC.

Profile

Company Names

RAPALOGIX HEALTH, INC.

Addresses

3129 TIGER RUN COURT, SUITE 207, CARLSBAD, CA 92010

228 PARK AVE S., SUITE 66643, NEW YORK, NY 10003

228 PARK AVE S, SUITE 66643, NEW YORK, NY 10003

Phone Numbers

(760) 707-2412
(650)856-3700
(650) 856-3700

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2023

State Incorporated:

DELAWARE

Total Amount Raised:

$28,192,362.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2026-06-22 
$19,112,746.00 
$24,999,999.00 
$5,887,253.00 
Equity 
1
2023-12-22 
$9,079,616.00 
$13,500,000.00 
$4,420,384.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DORIS 
 
DAY 
DIRECTOR
RAPALOGIX HEALTH, INC.
NEETU 
 
DHALIWAL 
DIRECTOR
RAPALOGIX HEALTH, INC.
CRAIG 
 
GORDON 
DIRECTOR
OTR GLOBAL HOLDINGS II, INC.   |  KOLLECTIVE TECHNOLOGY, INC.   |  ANTIOS THERAPEUTICS INC.   |  SALIOGEN THERAPEUTICS, INC.   |  GENNAO BIO, INC.   |  AMLOGENYX INC.   |  RAPALOGIX HEALTH, INC.
JULIETTE 
 
HAN 
DIRECTOR, EXECUTIVE OFFICER
RAPALOGIX HEALTH, INC.
JOAN 
 
MANNICK 
DIRECTOR
RAPALOGIX HEALTH, INC.
RAHUL 
 
MEHTA 
EXECUTIVE OFFICER
CONSCIOUS STEP, INC.   |  RAPALOGIX HEALTH, INC.
DAVID 
 
NICHOLSON 
DIRECTOR
ACTINIUM PHARMACEUTICALS, INC.   |  ACTINIUM PHARMACEUTICALS, INC.   |  LA MEND, INC.   |  BABOON MEGA CORP, INC.   |  VOLASTRA THERAPEUTICS, INC.   |  RAPALOGIX HEALTH, INC.
JAMES 
 
PEYER 
DIRECTOR
DELOS PHARMACEUTICALS, INC.   |  VITA THERAPEUTICS, INC.   |  RAPALOGIX HEALTH, INC.
BRENT 
 
SAUNDERS 
DIRECTOR, EXECUTIVE OFFICER
ELECTROCORE, LLC   |  SCIFLUOR LIFE SCIENCES, INC.   |  OCUTERRA THERAPEUTICS, INC.   |  ARS PHARMACEUTICALS, INC.   |  ROAM HQ INC.   |  GLO PHARMA, INC.   |  RAPALOGIX HEALTH, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-06-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2026-06-22 
2025-06-04
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-12-22 
2024-01-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-12-22 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#